Key facts
- It has raised $33.9B; the latest was General Corporate Purpose ($1.9B) in Nov 2025.
- Notable investors include Goshawk Asset Management.
- Status: Publicly Held.
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Roche Holdings
- ·The full record, as it builds
Funding rounds
No funding rounds for Roche Holdings are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Roche Holdings
Provider of pharmaceutical and diagnostic solutions based in San Francisco, California. The company offers advanced DNA tests, diabetes monitoring supplies and point-of-care diagnostics.
- Sector
- Financial Services
- HQ
- San Francisco, CA, United States
- Founded
- 1987
- Ownership
- Publicly Held
Roche Holdings doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Roche Holdings shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Roche Holdings in its N-PORT filings yet. We sweep new filings monthly.